rss
Sex Transm Infect doi:10.1136/sti.2007.026740

Update on lymphogranuloma venereum in the UK

  1. Heather Jebbari
  1. Health Protection Agency, United Kingdom
    1. Sarah Alexander
    1. Health Protection Agency, United Kingdom
      1. Helen Ward (h.ward{at}imperial.ac.uk)
      1. Imperial College London, United Kingdom
        1. Barry Evans
        1. Health Protection Agency, United Kingdom
          1. Maria Solomou
          1. Health Protection Agency, United Kingdom
            1. Alicia Thornton
            1. Health Protection Agency, United Kingdom
              1. Gillian Deans
              1. Claude Nicol Centre, United Kingdom
                1. John White
                1. Guys and St Thomas's Hospital London, United Kingdom
                  1. Patrick D French (pfrench{at}gum.ucl.ac.uk)
                  1. Camden Primary Care Trust, United Kingdom
                    1. Catherine A Ison (catherine.ison{at}hpa.org.uk)
                    1. Health Protection Agency, United Kingdom
                      • Published Online First 25 June 2007

                      Abstract

                      Objectives: This report updates the UK epidemiology of Lymphogranuloma venereum (LGV) to the end of April 2007.

                      Methods: The Health Protection Agency's Centre for Infections undertakes laboratory testing for LGV and subsequent epidemiological investigation of cases after laboratory confirmation of the LGV serovars (L1-3). Data analysis of enhanced surveillance and laboratory reports was undertaken.

                      Results: From October 2004 to end April 2007, 492 cases of LGV have been diagnosed and enhanced surveillance forms have been returned for 423. Cases peaked in the third quarter of 2005 with an average of 32 cases per month, while in 2006 this fell to 12 cases per month. Nationally the outbreak is focused in London, Brighton and the North West. All cases are in men, 99% of whom are MSM, with a median age of 40 and predominantly white ethnicity (91%). Co-infection remains considerable: HIV (74%); hepatitis C (14%); syphilis (5%); and other STIs including gonorrhoea, genital herpes and hepatitis B. The number of men reporting greater than 10 sexual contacts in the previous 3 months has reduced from 23% (47) to 13% (15) from 2005-2006.

                      Discussion: The epidemic continues in the mostly white MSM population of the UK. The demographics of LGV remain similar to those previously described and high levels of HIV co-infection continue. Reduced numbers of sexual contacts may be contributing to the reduced numbers of LGV seen in 2006 but may simply mean that LGV is moving out of the highest risk groups.

                      Register for free content

                      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

                      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.